Syneron Medical Ltd (ELOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2004 | 06-2004 | |
| Sales | 15,144 | 13,717 |
| Gross Profit | 15,144 | 13,717 |
| Operating Income | 15,144 | 13,717 |
| Pre-tax Income | 15,144 | 13,717 |
| Net Income Continuous | 7,250 | 6,435 |
| Net Income | $7,250 | $6,435 |
| EPS Basic Total Ops | 0.37 | 0.39 |
| EPS Basic Continuous Ops | 0.37 | 0.39 |
| EPS Diluted Total Ops | 0.29 | 0.30 |
| EPS Diluted Continuous Ops | 0.29 | 0.30 |
| EBITDA(a) | $15,144 | $13,717 |